Evidence map›Paper›PMID 25651849›Full record

ArticleBMC complementary and alternative medicine2015

Effect of the crude extract of Eugenia uniflora in morphogenesis and secretion of hydrolytic enzymes in Candida albicans from the oral cavity of kidney transplant recipients.

Walicyranison Plinio Silva-Rocha, Vitor Luiz de Brito Lemos, Magda Rhayanny Assunção Ferreira, Luiz Alberto Lira Soares, Terezinha Inês Estivalet Svidzisnki, Eveline Pipolo Milan, Guilherme Maranhão Chaves

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Phenotypic and Molecular Characterization ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Influence of Major Polyphenols on the Anti-Molecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Bioprospecting a Film-Forming System Loaded withPharmaceuticals (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Targeting Virulence Factors ofFoods (Basel, Switzerland) · 2022
    Review
  12. Evaluation of Anti-Journal of fungi (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Efficacy ofCurrent medical mycology · 2022
    Article
  15. In vitro activities ofCurrent medical mycology · 2020
    Article
  16. Article
  17. Infection and drug resistance · 2019
    Article
  18. Article
  19. Effect of the Ethyl Acetate Fraction ofFrontiers in microbiology · 2017
    Article
  20. Evaluation of Virulence FactorsFrontiers in microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Walicyranison Plinio Silva-RochaLaboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. wrplinio@hotmail.com.
Vitor Luiz de Brito LemosLaboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. vitorluiz_06@yahoo.com.br.
Magda Rhayanny Assunção FerreiraDepartamento de Farmácia, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil. magda_nani@hotmail.com.
Luiz Alberto Lira SoaresDepartamento de Farmácia, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil. phtech@uol.com.br.
Terezinha Inês Estivalet SvidzisnkiDepartamento de Análises Clínicas, Universidade Estadual de Maringá, Maringá, Paraná, Brazil. terezinha@email.com.
Eveline Pipolo MilanDepartamento de Infectologia, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. evepipolo@gmail.com.
Guilherme Maranhão ChavesLaboratório de Micologia Médica e Molecular, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. guilherme.chaves@ufrnet.br.
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCandida albicans is a diploid yeast that in some circumstances may cause oral or oropharyngeal infections. Yeasts virulence factors contribute for both the maintenance of colonizing strains in addition to damage and cause tissue invasion, thus the establishment of infection occurs. The limited arsenal of antifungal drugs for the treatment of candidiasis turn the investigation of natural products mandatory for the discovery of new targets for antifungal drug development. Therefore, tropical countries emerge as important providers of natural products with potential antimicrobial activity. This study aimed to investigate morphogenesis and secretion of hydrolytic enzymes (phospholipase and proteinase) in the presence of the CE of Eugenia uniflora.

methodsThe isolates were tested for their ability to form hyphae in both solid and liquid media under three different conditions: YPD + 20% FBS, Spider medium and GlcNac and the ability to secrete phospholipase and proteinase in the presence of 2000 μg/mL of E. uniflora.

resultsThe CE of E. uniflora inhibited hypha formation in both liquid and solid media tested. It also impaired hydrolytic enzymes production.

conclusionsThis was the first study to describe the interaction of a natural product with the full expression of three different factors in C. albicans. E. uniflora may be an alternative therapeutic for oral candidiasis in the future.

Indexed as

PhytotherapySyzygiumAntifungal AgentsCandida albicansCandidiasis, OralComplex MixturesHumansHydrolysisHyphaeKidneyKidney TransplantationMorphogenesisPeptide HydrolasesPhospholipasesPlant ExtractsTransplant RecipientsAntifungal AgentsComplex MixturesPeptide HydrolasesPhospholipasesPlant ExtractsVirulence Factors

Identifiers

PMID25651849
PMCPMC4324049
OpenAlexW1982863839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.